News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
PuriCore to Launch New Animal Health Wound Irrigant NovaZo at ACVS
10/22/2013 11:05:24 AM
MALVERN, PA (October 22, 2013) – PuriCore (LSE: PURI), a global company focused on safe and effective
protection against the spread of infectious pathogens, today announced the launch of NovaZo™ Animal Health
Wound Irrigation Solution at the upcoming 2013 American College of Veterinarian Surgeons (ACVS)
Symposium, to be held October 24 to 26 in San Antonio, TX. This new animal health product is based on
PuriCore’s Vashe Wound Therapy products for humans, which have been FDA-cleared and on the market for
five years. NovaZo is a safe and effective wound cleanser for use on companion and large animals of all
species including competitive animals. Currently, NovaZo is available through veterinarians in the US and will
be available internationally later in 2013.
NovaZo is used in the management of post-surgical incisions; moist dressings; hot spots, bites, and rashes;
burn, graft, and flap dressings; and for debridement irrigation and odor control. It can be dispensed for home
and farm use. It is safe for use around an animal’s mouth, nose, eyes, and ears and is non-cytotoxic, nonstinging,
and steroid-free. NovaZo will be sold direct by PuriCore in 12-packs of 475-ml bottles. The list price of
NovaZo is $39.99 per bottle ($479.88 per case). PuriCore will also continue to pursue partnering discussions
both in the US and internationally. More information on NovaZo is available at www.novazo.com.
“NovaZo is a breakthrough for wound management in all animals—from cats, dogs, and exotic pets to horses
and cattle and even competitive animals,” said Michael Ashton, PuriCore Executive Chairman. “In early market
testing, veterinarians found that this one-step product to be very versatile, easy to use in the clinic as well as at
home and on farms as directed, and very safe for the animals even when used around the most sensitive
“In my clinical use of NovaZo, I am impressed with the amount of debris that comes off the wound without my
having to touch it,” said Frank H. Welker, DVM, MS, The Ohio State University College of Veterinary Medicine.
“NovaZo has a high concentration of HOCl and is hypochlorite-free, making it skin-friendly and noncytotoxic.
This, in comparison to potentially cytotoxic solutions containing povidone-iodine, chlorhexadine, and
hypochlorite, represents a novel advancement in animal wound care.”
Sage Strategic Marketing
PuriCore plc (LSE: PURI) is a global company focused on safe and effective protection against the spread of
infectious pathogens without causing harm to human or animal health or to the environment. PuriCore’s
antimicrobial technology and complementary products are used in well-established core businesses and
emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences
market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and
compliant endoscope decontamination to protect patients and staff in UK hospitals. PuriCore’s breakthrough
wound care technology is used to treat chronic and acute wounds including diabetic ulcers and burns in
humans, for atopic dermatitis as private-labelled dermatologic treatments for humans, and to manage wounds
in all species of companion and farm animals in the animal health segment. In the Food & Agriculture market,
PuriCore’s portfolio is used by three of the top-five US supermarket retailers to provide savings in labour costs
and improvements in inventory loss and to address cross contamination of pathogens on fresh produce and
floral products. In addition, the Company is progressing its research and development programs on the use of
its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations
in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.
Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts
but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions.
Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify
forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks,
uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to
differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and
prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of
the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which
the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forwardlooking
statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as
required by law or by any appropriate regulatory authority.
Help employers find you! Check out all the jobs and post your resume.